scispace - formally typeset
A

Andrzej Jaworek

Researcher at Jagiellonian University Medical College

Publications -  51
Citations -  287

Andrzej Jaworek is an academic researcher from Jagiellonian University Medical College. The author has contributed to research in topics: Atopic dermatitis & SCORAD. The author has an hindex of 8, co-authored 48 publications receiving 211 citations.

Papers
More filters
Journal ArticleDOI

Protective Effect of Melatonin on Acute Pancreatitis

TL;DR: The beneficial effects of melatonin shown in experimental studies suggest that melatonin ought to be employed in the clinical trials as a supportive therapy in acute pancreatitis and could be used in people at high risk for acute Pancreasitis to prevent the development of pancreatic inflammation.
Journal Article

[Psychodermatology: psychological and psychiatrical aspects of dermatology].

TL;DR: This article characterises the particular disorders with their dermatological and psychological aspects and the basic principles of therapeutic interventions for each disorder are discussed.
Journal ArticleDOI

Pinealectomy aggravates acute pancreatitis in the rat

TL;DR: Treatment with melatonin prevented the development of AP in the sham-operated rats and significantly reduced pancreatic inflammation in the animals previously subjected to pinealectomy, contributing to the pancreatic protection through the activation of the antioxidative defense mechanism in pancreatic tissue as well as its direct antioxidant effects.
Journal ArticleDOI

Elevated cerebrospinal fluid interleukin-17A and interferon-γ levels in early asymptomatic neurosyphilis.

TL;DR: Increased CSF levels of IFN-&ggr; and IL-17A in syphilitic patients with CSF abnormalities suggest that cells of adaptive immunity may contribute to the inflammatory response associated with neurosyphilis, and the lack of correlation between serum and CSF IL- 17A levels suggests intrathecal production of this cytokine.
Journal ArticleDOI

Adipokines as Biomarkers of Atopic Dermatitis in Adults.

TL;DR: Adiponectin and resistin are pointed to as the potential candidate adipokine biomarkers involved in shaping eczema intensity and severity, which may help predict disease exacerbations and enable the development of effective targeted therapeutic interventions.